| Nash Allen Kawela Witten, MD | |
|
66-125 Kamehameha Hwy, Haleiwa, HI 96712-1601 | |
| (808) 637-5087 | |
| (808) 637-4765 |
| Full Name | Nash Allen Kawela Witten |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 7 Years |
| Location | 66-125 Kamehameha Hwy, Haleiwa, Hawaii |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1790211431 | NPI | - | NPPES |
| A184745 | Other | CA | MEDICAL LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MD-20991 (Hawaii) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Bristol Hospice - Hawaii, Llc | Honolulu, HI | Hospice |
| The Queens Medical Center | Honolulu, HI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Queens University Medical Group | 2466831557 | 543 |
| Waianae District Comprehensive Health And Hospital Board, Incorporated | 9931008349 | 113 |
News Archive
The Juvenile Diabetes Research Foundation has said that while the NIH is doing its best to accelerate progress in the field of embryonic stem cells, any success would remain minimal so long as the current Administration policy severely limits federal funding for stem cell research.
Physicians in the UK are calling for improved warnings and more child-proof packaging for liquid cleaning capsules after a number of incidents in which toddlers were hospitalized after swallowing them.
Scientists and physicians at University of California San Diego School of Medicine, working with colleagues at the U.S. Navy Medical Research Center - Biological Defense Research Directorate, Texas A&M University, a San Diego-based biotech and elsewhere, have successfully used an experimental therapy involving bacteriophages - viruses that target and consume specific strains of bacteria - to treat a patient near death from a multidrug-resistant bacterium.
Ipsen Biopharmaceuticals, Inc., the U.S. affiliate of Ipsen today announced that it has submitted a Supplemental New Drug Application to the U.S. Food and Drug Administration for Somatuline Depot 120mg injection for the treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs).
› Verified 5 days ago
| Entity Name | Waianae District Comprehensive Health And Hospital Board, Incorporated |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275566424 PECOS PAC ID: 9931008349 Enrollment ID: O20040105000833 |
News Archive
The Juvenile Diabetes Research Foundation has said that while the NIH is doing its best to accelerate progress in the field of embryonic stem cells, any success would remain minimal so long as the current Administration policy severely limits federal funding for stem cell research.
Physicians in the UK are calling for improved warnings and more child-proof packaging for liquid cleaning capsules after a number of incidents in which toddlers were hospitalized after swallowing them.
Scientists and physicians at University of California San Diego School of Medicine, working with colleagues at the U.S. Navy Medical Research Center - Biological Defense Research Directorate, Texas A&M University, a San Diego-based biotech and elsewhere, have successfully used an experimental therapy involving bacteriophages - viruses that target and consume specific strains of bacteria - to treat a patient near death from a multidrug-resistant bacterium.
Ipsen Biopharmaceuticals, Inc., the U.S. affiliate of Ipsen today announced that it has submitted a Supplemental New Drug Application to the U.S. Food and Drug Administration for Somatuline Depot 120mg injection for the treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs).
› Verified 5 days ago
| Entity Name | The Queens Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487693586 PECOS PAC ID: 3476454067 Enrollment ID: O20040116000366 |
News Archive
The Juvenile Diabetes Research Foundation has said that while the NIH is doing its best to accelerate progress in the field of embryonic stem cells, any success would remain minimal so long as the current Administration policy severely limits federal funding for stem cell research.
Physicians in the UK are calling for improved warnings and more child-proof packaging for liquid cleaning capsules after a number of incidents in which toddlers were hospitalized after swallowing them.
Scientists and physicians at University of California San Diego School of Medicine, working with colleagues at the U.S. Navy Medical Research Center - Biological Defense Research Directorate, Texas A&M University, a San Diego-based biotech and elsewhere, have successfully used an experimental therapy involving bacteriophages - viruses that target and consume specific strains of bacteria - to treat a patient near death from a multidrug-resistant bacterium.
Ipsen Biopharmaceuticals, Inc., the U.S. affiliate of Ipsen today announced that it has submitted a Supplemental New Drug Application to the U.S. Food and Drug Administration for Somatuline Depot 120mg injection for the treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs).
› Verified 5 days ago
| Entity Name | Queens University Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891441382 PECOS PAC ID: 2466831557 Enrollment ID: O20220621000534 |
News Archive
The Juvenile Diabetes Research Foundation has said that while the NIH is doing its best to accelerate progress in the field of embryonic stem cells, any success would remain minimal so long as the current Administration policy severely limits federal funding for stem cell research.
Physicians in the UK are calling for improved warnings and more child-proof packaging for liquid cleaning capsules after a number of incidents in which toddlers were hospitalized after swallowing them.
Scientists and physicians at University of California San Diego School of Medicine, working with colleagues at the U.S. Navy Medical Research Center - Biological Defense Research Directorate, Texas A&M University, a San Diego-based biotech and elsewhere, have successfully used an experimental therapy involving bacteriophages - viruses that target and consume specific strains of bacteria - to treat a patient near death from a multidrug-resistant bacterium.
Ipsen Biopharmaceuticals, Inc., the U.S. affiliate of Ipsen today announced that it has submitted a Supplemental New Drug Application to the U.S. Food and Drug Administration for Somatuline Depot 120mg injection for the treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs).
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Nash Allen Kawela Witten, MD 86-260 Farrington Hwy Fl 2, Waianae, HI 96792-3128 Ph: (808) 697-3490 | Nash Allen Kawela Witten, MD 66-125 Kamehameha Hwy, Haleiwa, HI 96712-1601 Ph: (808) 637-5087 |
News Archive
The Juvenile Diabetes Research Foundation has said that while the NIH is doing its best to accelerate progress in the field of embryonic stem cells, any success would remain minimal so long as the current Administration policy severely limits federal funding for stem cell research.
Physicians in the UK are calling for improved warnings and more child-proof packaging for liquid cleaning capsules after a number of incidents in which toddlers were hospitalized after swallowing them.
Scientists and physicians at University of California San Diego School of Medicine, working with colleagues at the U.S. Navy Medical Research Center - Biological Defense Research Directorate, Texas A&M University, a San Diego-based biotech and elsewhere, have successfully used an experimental therapy involving bacteriophages - viruses that target and consume specific strains of bacteria - to treat a patient near death from a multidrug-resistant bacterium.
Ipsen Biopharmaceuticals, Inc., the U.S. affiliate of Ipsen today announced that it has submitted a Supplemental New Drug Application to the U.S. Food and Drug Administration for Somatuline Depot 120mg injection for the treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs).
› Verified 5 days ago
Dr. Randall Suzuka, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 66-125 Kamehameha Hwy, Haleiwa, HI 96712 Phone: 808-637-5087 Fax: 808-637-4765 | |
Mr. Adrian Izweriw, DNP, APRN-RX Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 59-233 Ke Nui Rd, Haleiwa, HI 96712 Phone: 808-636-4980 | |
Dr. Leland Henry Dao, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 66-150 Kamehameha Hwy, Haleiwa, HI 96712 Phone: 808-637-8416 Fax: 888-509-7985 | |
Dr. Vanessa Mae Agsalda-rosenbush, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 66-125 Kamehameha Hwy, Haleiwa, HI 96712 Phone: 808-637-5087 Fax: 808-637-4765 | |
Aaron Kaoru Suzuka, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 66-125 Kamehameha Hwy, Haleiwa, HI 96712 Phone: 808-691-8501 | |
Dr. Summer Reiko Teruya, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 66-125 Kamehameha Hwy, Haleiwa, HI 96712 Phone: 808-637-5087 |